• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

迷幻剂:从洞穴艺术到 21 世纪的成瘾医学。

Psychedelics: From Cave Art to 21st-Century Medicine for Addiction.

机构信息

Division of Brain Sciences, Centre for Psychiatry, Imperial College London, Commonwealth Building, Hammersmith Campus, London, UK,

Division of Brain Sciences, Centre for Psychiatry, Imperial College London, Commonwealth Building, Hammersmith Campus, London, UK.

出版信息

Eur Addict Res. 2024;30(5):302-320. doi: 10.1159/000540062. Epub 2024 Sep 25.

DOI:10.1159/000540062
PMID:39321788
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11527458/
Abstract

BACKGROUND

Psychedelic substance use in ritualistic and ceremonial settings dates back as early as 8,500 BCE. Only in recent years, from the mid-20th century, we have seen the re-emergence of psychedelics in a therapeutic setting and more specifically for the treatment of addiction. This article aims to review research over the past 40 years using classic (psilocybin, lysergic acid diethylamide [LSD], dimethyltryptamine [DMT], mescaline) and atypical (ketamine, ibogaine, 5-MeO-DMT, 3,4-methylenedioxymethamphetamine) psychedelics for the treatment of addiction.

SUMMARY

We will start with an overview of the pharmacology and physiological and psychological properties of psychedelic substances from pre-clinical and clinical research. We will then provide an overview of evidence gathered by studies conducted in controlled research environments and naturalistic and ceremonial settings, while we identify the proposed therapeutic mechanisms of each psychedelic substance.

KEY MESSAGES

Classic and atypical psychedelics show promise as therapeutic alternatives for the treatment of addiction, through the improvement of psychological and physiological symptoms of dependence. A more comprehensive understanding of the ancient and present-day knowledge of the therapeutic potential of psychedelics can facilitate hope for psychedelic therapeutics in the treatment of addiction, especially for individuals who have failed other conventional treatment methods.

摘要

背景

仪式和典礼中使用迷幻药物的历史可以追溯到公元前 8500 年。直到最近几十年,从 20 世纪中期开始,我们才看到迷幻药物在治疗环境中重新出现,特别是用于治疗成瘾。本文旨在回顾过去 40 年使用经典(裸盖菇素、麦角酸二乙酰胺[LSD]、二甲色胺[DMT]、三甲氧苯乙胺[mescaline])和非典型(氯胺酮、伊博加因、5-MeO-DMT、3,4-亚甲二氧基甲基苯丙胺)迷幻药物治疗成瘾的研究。

摘要

我们将首先概述迷幻药物的药理学和生理心理特性,从临床前和临床研究中获得。然后,我们将概述在受控研究环境和自然及仪式环境中进行的研究中收集的证据,同时确定每种迷幻药物的拟议治疗机制。

关键信息

经典和非典型迷幻药物显示出作为治疗成瘾的替代疗法的潜力,通过改善依赖的心理和生理症状。更全面地了解迷幻药物的古代和现代治疗潜力的知识,可以为迷幻药物治疗在治疗成瘾方面带来希望,特别是对于那些已经尝试过其他常规治疗方法的人。

相似文献

1
Psychedelics: From Cave Art to 21st-Century Medicine for Addiction.迷幻剂:从洞穴艺术到 21 世纪的成瘾医学。
Eur Addict Res. 2024;30(5):302-320. doi: 10.1159/000540062. Epub 2024 Sep 25.
2
Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.迷幻剂:治疗情绪和焦虑障碍的替代和潜在治疗选择。
Molecules. 2022 Apr 14;27(8):2520. doi: 10.3390/molecules27082520.
3
Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders.超越裸盖菇素:综述其他血清素能致幻剂在精神和物质使用障碍中的治疗潜力。
J Psychoactive Drugs. 2024 Sep-Oct;56(4):513-529. doi: 10.1080/02791072.2023.2251133. Epub 2023 Aug 24.
4
Psychedelics for treatment resistant depression: are they game changers?治疗抵抗性抑郁症的致幻剂:它们是游戏规则改变者吗?
Expert Opin Pharmacother. 2023 Sep-Dec;24(18):2117-2132. doi: 10.1080/14656566.2023.2281582. Epub 2024 Jan 5.
5
Can psychedelics have a role in psychiatry once again?迷幻药能否再次在精神病学领域发挥作用?
Br J Psychiatry. 2005 Jun;186:457-8. doi: 10.1192/bjp.186.6.457.
6
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.创伤后应激障碍治疗的迷幻未来。
Curr Neuropharmacol. 2024;22(4):636-735. doi: 10.2174/1570159X22666231027111147.
7
Psychedelic drugs: the ups and downs of ecstasy.迷幻药物:摇头丸的起起落落
Nature. 2004 May 13;429(6988):126-8. doi: 10.1038/429126a.
8
The use of classic psychedelics among adults: a Danish online survey study.成年人中经典迷幻剂的使用:一项丹麦在线调查研究。
Nord J Psychiatry. 2023 May;77(4):367-378. doi: 10.1080/08039488.2022.2125069. Epub 2022 Sep 29.
9
Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation.经典迷幻剂在成瘾治疗中的应用:以 psilocybin 为例治疗烟草依赖。
Curr Top Behav Neurosci. 2022;56:213-227. doi: 10.1007/7854_2022_327.
10
Dosing Psychedelics and MDMA.致幻剂和 MDMA 的给药剂量。
Curr Top Behav Neurosci. 2022;56:3-21. doi: 10.1007/7854_2021_270.

引用本文的文献

1
Exploring the therapeutic potential of psychedelics in treating substance use disorders.探索迷幻药在治疗物质使用障碍方面的治疗潜力。
Mol Psychiatry. 2025 Aug 19. doi: 10.1038/s41380-025-03168-w.
2
The psychedelic-peptide paradox: a hormetic hypothesis.致幻肽悖论:一种 hormetic 假说。 (注:hormetic 可能是个特定专业术语,未找到完全对应的准确中文,可根据具体学科领域进一步确定合适译法,这里暂保留英文)
Compr Psychoneuroendocrinol. 2025 Jun 2;23:100303. doi: 10.1016/j.cpnec.2025.100303. eCollection 2025 Aug.

本文引用的文献

1
Psychedelic therapy in the treatment of addiction: the past, present and future.迷幻疗法在成瘾治疗中的应用:过去、现在与未来
Front Psychiatry. 2023 Jun 12;14:1183740. doi: 10.3389/fpsyt.2023.1183740. eCollection 2023.
2
Mescaline: The forgotten psychedelic.三甲氧苯乙胺:被遗忘的迷幻剂。
Neuropharmacology. 2023 Jan 1;222:109294. doi: 10.1016/j.neuropharm.2022.109294. Epub 2022 Oct 14.
3
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial.裸盖菇素辅助心理治疗与安慰剂治疗酒精使用障碍成年患者后重度饮酒日的百分比:一项随机临床试验。
JAMA Psychiatry. 2022 Oct 1;79(10):953-962. doi: 10.1001/jamapsychiatry.2022.2096.
4
The effects of MDMA-assisted therapy on alcohol and substance use in a phase 3 trial for treatment of severe PTSD.在一项治疗严重创伤后应激障碍的 3 期试验中,MDMA 辅助治疗对酒精和物质使用的影响。
Drug Alcohol Depend. 2022 Apr 1;233:109356. doi: 10.1016/j.drugalcdep.2022.109356. Epub 2022 Feb 11.
5
Exploring protective associations between the use of classic psychedelics and cocaine use disorder: a population-based survey study.探讨经典迷幻剂使用与可卡因使用障碍之间的保护关联:一项基于人群的调查研究。
Sci Rep. 2022 Feb 16;12(1):2574. doi: 10.1038/s41598-022-06580-2.
6
Adverse effects of psychedelics: From anecdotes and misinformation to systematic science.迷幻剂的不良反应:从传闻和错误信息到系统科学。
J Psychopharmacol. 2022 Mar;36(3):258-272. doi: 10.1177/02698811211069100. Epub 2022 Feb 2.
7
Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review.氯胺酮用于治疗精神健康和物质使用障碍:全面系统评价
BJPsych Open. 2021 Dec 23;8(1):e19. doi: 10.1192/bjo.2021.1061.
8
Adjunctive Ketamine With Relapse Prevention-Based Psychological Therapy in the Treatment of Alcohol Use Disorder.辅助氯胺酮联合基于预防复发的心理治疗用于酒精使用障碍的治疗
Am J Psychiatry. 2022 Feb;179(2):152-162. doi: 10.1176/appi.ajp.2021.21030277. Epub 2022 Jan 11.
9
Psychedelic use is associated with reduced daily opioid use among people who use illicit drugs in a Canadian setting.在加拿大,致幻剂的使用与非法药物使用者每日阿片类药物使用量减少有关。
Int J Drug Policy. 2022 Feb;100:103518. doi: 10.1016/j.drugpo.2021.103518. Epub 2021 Nov 7.
10
United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020.美国国立卫生研究院(NIH)2006 年至 2020 年期间为迷幻辅助治疗临床试验提供的资助。
Int J Drug Policy. 2022 Jan;99:103473. doi: 10.1016/j.drugpo.2021.103473. Epub 2021 Oct 6.